HealthcareServices

Myopia and Presbyopia Treatment Market 2026–2030: Forecasting Business Opportunities Ahead

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the myopia and presbyopia treatment market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Myopia and Presbyopia Treatment Market from 2026 to 2030?

The myopia and presbyopia treatment market size has demonstrated robust expansion in recent years. This market is projected to increase from $22.63 billion in 2025 to $24.56 billion in 2026, at a compound annual growth rate (CAGR) of 8.6%. Historically, this growth can be ascribed to an expanding aging population, the widespread adoption of corrective lenses, a rise in screen-induced myopia, early advancements in refractive surgery, and limited public awareness of preventive eye care.

The myopia and presbyopia treatment market size is anticipated to experience robust expansion in the coming years. This market is projected to reach $33.57 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. During the forecast period, this expansion is driven by several factors, including the increasing need for sophisticated surgical options, the greater uptake of lenses designed to correct presbyopia, the growing application of pharmacological therapies, advancements in eye care diagnostic technologies, and the broadening of preventive screening initiatives. Key developments expected in this period encompass the wider acceptance of multifocal and advanced contact lenses, an escalating call for laser and refractive surgical interventions, a rising inclination towards orthokeratology (ortho-k) for managing myopia, increased application of pharmacological eye drops specifically for presbyopia, and the broadening of early vision checks and preventative care strategies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7892&type=smp

What Drivers Are Affecting Demand In The Myopia and Presbyopia Treatment Market?

The increasing incidence of vision impairment is anticipated to stimulate the expansion of the myopia and presbyopia treatment market moving forward. Vision impairment describes a state where an individual’s capacity to see and interpret visual information is considerably diminished, leading to difficulties in perceiving and understanding their surroundings. The growing prevalence of vision impairment has the potential to accelerate the development of myopia and presbyopia treatments, fostering heightened awareness, promoting innovation, attracting investments, improving access to therapies, and ultimately yielding better outcomes for those seeking remedies for their visual issues. For instance, in August 2023, according to the World Health Organization (WHO), a Switzerland-based United Nations agency, global estimates indicate that 2.2 billion people have near or distance vision impairment, including 1 billion cases that are preventable or untreated. Refractive errors and cataracts remain the leading global causes of vision loss, yet only 36% of individuals with refractive-error–related distance impairment and merely 17% of those with cataract-related impairment have received appropriate care. Consequently, the escalating rate of vision impairment is propelling the growth of the myopia and presbyopia treatment market.

Which Segments Are Gaining Traction In The Myopia and Presbyopia Treatment Market?

The myopia and presbyopia treatment market covered in this report is segmented –

1) By Type: Myopia, Presbyopia

2) By Age Group: Children And Young Adults, Adults, Geriatrics

3) By End-Use: Hospitals, Eye Care Clinics Or Ophthalmic Centers

Subsegments:

1) By Myopia: Pharmacological Treatments, Orthokeratology Lenses, Refractive Surgery, Spectacles And Contact Lenses

2) By Presbyopia: Multifocal Lenses, Monovision Contact Lenses, Corneal Inlays, Presbyopia-Correcting Surgery

Which Innovation Trends Are Advancing Developments Within The Myopia and Presbyopia Treatment Market?

Leading companies within the myopia and presbyopia treatment market are innovating products, such as myopia combating sun spectacle lenses, to serve larger customer bases, boost sales, and increase revenue. Myopia-combating sun spectacle lenses are specific eyeglass lenses crafted to help slow the progression of myopia, also known as near-sightedness, when worn in outdoor or bright sunlight conditions. For instance, in May 2023, HOYA, an optical technology company based in Thailand, launched MiYOSMART sun spectacle lenses aimed at combating myopia in children. A distinctive feature of MiYOSMART is its innovative strategy to decelerate myopia progression in children alongside offering protection from intense sunlight. This goal is achieved via two specialized lens options: the photochromic spectacle lenses, MiYOSMART Chameleon, and the polarized spectacle lenses, MiYOSMART Sunbird, both integrating DIMS Technology (Defocus Incorporated Multiple Segments). Developed jointly with the Hong Kong Polytechnic University, DIMS Technology functions on the principle of generating simultaneous defocus for both distance and near vision. This mechanism establishes one plane on the retina from the lens’s single vision zone(s), while a second plane produces myopic defocus through the incorporation of +3.50D defocus lenslets.

Who Are The Prominent Global Companies Shaping The Myopia and Presbyopia Treatment Market Landscape?

Major companies operating in the myopia and presbyopia treatment market are ALCON Inc., Bausch & Lomb Incorporated, Carl Zeiss AG, Essilor Ltd., Johnson & Johnson Vision Inc., Nidek Corporation, Topcon Corporation, Zimmer Ophthalmic Systems AG, AbbVie Inc., Orasis Pharmaceuticals Ltd., The Cooper Companies Inc., Staar Surgical Co., Eyenovia Inc., Allergan PLC, Hoya Corporation, Menicon Co. Ltd., CooperVision Inc., Visioneering Technologies Inc., AcuFocus Inc., Ocular Therapeutix Inc., SightGlass Vision Inc., Presbia PLC, LensGen Inc., RxSight Inc., Perfect Lens LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/myopia-and-presbyopia-treatment-global-market-report

Which Region Is Projected To Lead The Myopia and Presbyopia Treatment Market During The Forecast Period?

North America was the largest region in the myopia and presbyopia treatment market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myopia and presbyopia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Myopia and Presbyopia Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7892&type=smp

Browse Through More Reports Similar to the Global Myopia and Presbyopia Treatment Market 2026, By The Business Research Company

Retinal Disorder Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

Amblyopia Market Report 2026

https://www.thebusinessresearchcompany.com/report/amblyopia-global-market-report

Ocular Hypertension Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/ocular-hypertension-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795